Showing results (2051-2060 of 3,507) with videos related to
Sort By:
Pageof 351
Eclinicalmedicine|July 31, 2025
Evaluation of clinical and safety outcomes of cancer vaccines in patients with advanced non-small cell lung cancer after first-line therapy: a systematic review and meta-analysisShaoyi Chen, Zewen Sun, Yun Li, et al.Eclinicalmedicine|July 31, 2025
Co-occurrence and associated factors of developmental delay, functional disability, and undernutrition in early childhood: evidence from 15 population-based surveys in sub-Saharan African countriesChihao Yan, Shuangyu Zhao, Jingkai Cui, et al.Eclinicalmedicine|July 30, 2025
Towards universal early screening for cerebral palsy: a roadmap for automated General Movements AssessmentAlicia J Spittle, Peter B Marschik, Lars Adde, et al.Eclinicalmedicine|July 31, 2025
A core outcome set for research on masculinizing genital gender-affirming surgery: international consensus results from the GenderCOS projectPhilippine J Roijer, Marleen S Vallinga, Thomas E Pidgeon, et al.Eclinicalmedicine|July 29, 2025
Timing of intravenous iron for treatment of anaemia in surgical patients: a systematic review and network meta-analysisChang Liu, Jiashu Han, Renkui Fu, et al.Eclinicalmedicine|July 29, 2025
Optimal timing and mode of planned birth for term, large infants: a retrospective, population-based cohort studyGeorgia Anne Santomartino, Kylie Crawford, Jesrine Hong, et al.Eclinicalmedicine|August 4, 2025
Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 studyTomasz Wróbel, Elżbieta Kalicińska, Jan Maciej Zaucha, et al.Eclinicalmedicine|March 27, 2025
Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialNathalie M Rieser, Raoul Bitar, Simon Halm, et al.Eclinicalmedicine|November 5, 2020
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyBrian T Anderson, Alicia Danforth, Prof Robert Daroff, et al.Eclinicalmedicine|November 5, 2020
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind StudyMaria Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse, et al.Pageof 351